Jennison Associates LLC Novo Nordisk A S Transaction History
Jennison Associates LLC
- $162 Billion
- Q4 2024
A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 19,944,809 shares of NVO stock, worth $1.4 Billion. This represents 1.06% of its overall portfolio holdings.
Number of Shares
19,944,809
Previous 20,195,957
1.24%
Holding current value
$1.4 Billion
Previous $2.4 Billion
28.66%
% of portfolio
1.06%
Previous 1.5%
Shares
24 transactions
Others Institutions Holding NVO
# of Institutions
1,886Shares Held
335MCall Options Held
11.9MPut Options Held
10.6M-
Bank Of America Corp Charlotte, NC15.5MShares$1.09 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$912 Million1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$887 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$856 Million0.08% of portfolio
-
Loomis Sayles & CO L P11.6MShares$812 Million1.26% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $158B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...